Early Development & Construct Optimisation
Design support, construct refinement, and workflow scalability.
Multiple vendors and disconnected workflows slow programme progress and increase coordination risk. We provide a single, integrated partner from research to clinic.
Variability in RNA or plasmid DNA quality can compromise results and delay scale-up. Our controlled, reproducible processes ensure consistent performance from R&D to clinical supply.
Navigating compliance requirements can be resource-intensive and high risk. We align development with GMP and regulatory expectations from the outset.
Gaps in analytical support and process handovers increase development risk. Our integrated platform ensures traceability, documentation, and seamless progression at every stage.
Our CDMO capabilities cover the RNA product lifecycle, offering tailored solutions for each stage. From design to clinical-grade manufacturing, we adapt to project size and regulatory needs. By aligning with your milestones, we ensure seamless progression, reduce handovers, and maintain data continuity, allowing clients to accelerate timelines and focus on innovation.
Design support, construct refinement, and workflow scalability.
Robust, reproducible manufacturing from research-grade to clinical production.
Identity, purity, impurity profiling, and stability testing under controlled documentation.
Supply of research to clinical-grade mRNA and plasmid DNA, complete with regulatory documentation.
At Southern RNA, we integrate expertise, efficiency, and compliance into a seamless development pathway. We collaborate with clients from construct design to clinical-grade manufacturing, tailoring workflows to meet goals. Each project benefits from coordinated development, analytical support, and quality oversight, ensuring continuity and traceability. By connecting research, scale-up, and manufacturing, we reduce risk and accelerate timelines, allowing clients to focus on innovation.
Our process development team designs robust, reproducible methods, using data to guide optimisation and scale-up. This ensures smooth transition from research-grade material to GMP-aligned production while maintaining product quality.
In-house analytical capabilities provide identity verification, purity and impurity profiling, and stability assessment. Coupled with rigorous quality oversight, this ensures all outputs meet regulatory standards and programme requirements.
Our manufacturing infrastructure can adapt to different project scales, delivering research to clinical-grade RNA with complete documentation. This flexibility ensures reliable supply for early-phase trials and smooth regulatory submission.
Quality is central to Southern RNA. Our Quality Management System supports GMP operations and early-phase clinical manufacturing. From raw material qualification to final product release, every step follows documented procedures and risk assessments to ensure consistency and patient safety.
Compliance is embedded in our workflows, not just a final checkpoint. We maintain documentation systems, change management processes, and analytical verification to support regulatory submissions. By aligning quality oversight with execution, we help clients progress confidently from research to clinical supply.
Southern RNA has successfully supported multiple RNA programmes from early research through clinical supply. While client confidentiality is strictly maintained, examples of our capabilities include:
Efficiently increased production while maintaining quality and regulatory readiness for early clinical studies.
Robust, stage-aligned quality documentation and controls that support development, tech transfer, and regulatory progression.
Streamlined workflows and responsive project management to meet tight timelines without compromising quality or compliance.
Hands-on scientific support across nucleic acid design, synthesis, purification, and advanced analytical testing.
Comprehensive documentation and guidance aligned with clinical and regulatory expectations at every phase.
Our FAQ section addresses the most common technical and compliance queries, providing clarity on our capabilities, processes, and quality systems.
Yes, our facilities produce GMP-aligned and clinical-grade mRNA and plasmid DNA suitable for early-phase trials.
We follow GMP-aligned processes, robust documentation, and quality oversight to meet regulatory expectations and support submissions.
We offer flexible production from milligram-scale research material to multi-gram clinical-grade batches.
Yes, our in-house analytical team supports identity, purity, impurity profiling, and stability testing across all projects.
Absolutely. Our team develops reproducible processes for smooth transition from research-scale to GMP-aligned clinical production.
We provide a comprehensive nucleic acid analytical platform, supported by the deep expertise and experience of our multidisciplinary scientific team.
FIND OUT MORESouthern RNA offers quality plasmid DNA and mRNA for research and clinical use. Our scalable production ensures consistent quality, aiding RNA-based therapies.
EXPLORE OUR PRODUCTS